All Stories

  1. Longitudinal analyses of the steroid metabolome in obese PCOS girls with weight loss
  2. Should bariatric surgery be performed in adolescents?
  3. Impact of discontinuation of growth hormone treatment on lipids and weight status in adolescents
  4. Determination of 17OHPreg and DHEAS by LCMSMS: Impact of Age, Sex, Pubertal Stage and BMI on the Δ5-steroid-pathway
  5. Fibroblast growth factor 21 (FGF-21) in obese children: no relationship to growth, IGF-1, and IGFBP-3
  6. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes
  7. Blood Pressure in 57,915 Pediatric Patients Who Are Overweight or Obese Based on Five Reference Systems
  8. Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis
  9. Adipositas im Kindes- und Jugendalter
  10. Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents
  11. Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program
  12. Obesity Treatment Programmes
  13. Carotid intima-media thickness in children treated with growth hormone
  14. Strong Effect of Pubertal Status on Metabolic Health in Obese Children: A Longitudinal Study
  15. Cardiovascular Risk in Childhood Obesity
  16. Inpatient Lifestyle Interventions to Treat Childhood Obesity
  17. Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention
  18. Relationships Between 24-Hour Urinary Free Cortisol Concentrations and Metabolic Syndrome in Obese Children
  19. Is growth hormone treatment in children associated with weight gain? - Longitudinal analysis of KIGS data
  20. Changes in the serum metabolite profile in obese children with weight loss
  21. FTO Gene: Association to Weight Regain after Lifestyle Intervention in Overweight Children
  22. Predicting Weight Loss and Maintenance in Overweight/Obese Pediatric Patients
  23. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention
  24. Sensitivity analysis of weight reduction results of an observational cohort study in overweight and obese children and adolescents in Germany: the EvAKuJ Study
  25. Medical and psychosocial implications of adolescent extreme obesity – acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES)
  26. Relationship between Carotid Intima-Media Thickness and Metabolic Syndrome in Adolescents
  27. Health-related quality of life in overweight German children and adolescents: do treatment-seeking youth have lower quality of life levels? Comparison of a clinical sample with the general population using a multilevel model approach
  28. Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children
  29. Steroid Hormone Profiles in Prepubertal Obese Children Before and After Weight Loss
  30. HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database
  31. Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention
  32. Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss
  33. Ätiologie, Pathogenese, Diagnostik und Therapie des Diabetes mellitus Typ 1
  34. Adipositas
  35. Type 2 diabetes mellitus in children and adolescents
  36. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  37. Short Stature before Puberty: Which Children Should Be Screened for SHOX Deficiency?
  38. Screening for Co-Morbidity in 65,397 Obese Pediatric Patients from Germany, Austria and Switzerland: Adherence to Guidelines Improved from the Year 2000 to 2010
  39. Changes in self-reported and parent-reported health-related quality of life in overweight children and adolescents participating in an outpatient training: findings from a 12-month follow-up study
  40. Body Mass Index or Waist Circumference: Which Is the Better Predictor for Hypertension and Dyslipidemia in Overweight/Obese Children and Adolescents? Association of Cardiovascular Risk Related to Body Mass Index or Waist Circumference
  41. Rehabilitationund Adipositas
  42. TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children
  43. Mutation screen in the GWAS derived obesity gene SH2B1including functional analyses of detected variants
  44. Predicting Weight Loss of Obese Adolescents in Lifestyle Interventions by Genetic Screening: A Promising Approach for Researchers and Clinicians?
  45. Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
  46. Effect of Lifestyle Intervention on Features of Polycystic Ovarian Syndrome, Metabolic Syndrome, and Intima-Media Thickness in Obese Adolescent Girls
  47. SDCCAG8 Obesity Alleles and Reduced Weight Loss After a Lifestyle Intervention in Overweight Children and Adolescents
  48. Treatment with Gonadotropin-Releasing Hormone Analogues: Different Impact on Body Weight in Normal-Weight and Overweight Children
  49. Promotion and Provision of Drinking Water in Schools for Overweight Prevention
  50. Childhood Obesity Is Associated with Changes in the Serum Metabolite Profile
  51. Comorbidities Related to BMI Category in Children and Adolescents: German/Austrian/Swiss Obesity Register APV Compared to the German KiGGS Study
  52. Quality of Life in Children and Adolescents with Growth Hormone Deficiency: Association with Growth Hormone Treatment
  53. Do Common Variants Separate between Obese Melanocortin-4 Receptor Gene Mutation Carriers and Non-Carriers? The Impact of Cryptic Relatedness
  54. Longitudinal analyses of polysomnographic variables, serum androgens, and parameters of glucose metabolism in obese adolescents with polycystic ovarian syndrome
  55. Effect of Lifestyle Intervention on Features of Polycystic Ovarian Syndrome, Metabolic Syndrome, and Intima-Media Thickness in Obese Adolescent Girls
  56. Intima media thickness-related risk factors in childhood obesity
  57. Thyroid function in the nutritionally obese child and adolescent
  58. Effectiveness of lifestyle intervention in overweight children
  59. Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss
  60. Declining prevalence rates for overweight and obesity in German children starting school
  61. A Comparison of Polysomnographic Variables Between Adolescents with Polycystic Ovarian Syndrome with and without the Metabolic Syndrome
  62. Gamma-glutamyl Transferase Is Strongly Associated With Degree of Overweight and Sex
  63. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children
  64. Development and evaluation of the lifestyle intervention “Obeldicks light” for overweight children and adolescents
  65. Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents†
  66. Childhood obesity
  67. The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome
  68. Effect of Body Weight on Endocrine Parameters and Fat Hormones
  69. Genetic Markers, Weight Reduction, and Behavioral Changes in Lifestyle
  70. Treatment of Tall Stature in Boys: Comparison of Two Different Treatment Regimens
  71. Obesity in children and adolescents: relationship to growth, pubarche, menarche, and voice break
  72. Common Variants Near MC4R: Exploring Gender Effects in Overweight and Obese Children and Adolescents Participating in a Lifestyle Intervention
  73. Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome
  74. Former small for gestational age (SGA) status is associated to changes of insulin resistance in obese children during weight loss
  75. Obesity and thyroid function
  76. Immigrational Background Affects the Effectiveness of a School-based Overweight Prevention Program Promoting Water Consumption
  77. Changes of peripheral α-melanocyte–stimulating hormone in childhood obesity
  78. Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes After Weight Loss Due to Lifestyle Intervention
  79. Relationships between cardiovascular risk profile, ultrasonographic measurement of intra-abdominal adipose tissue, and waist circumference in obese children
  80. Endokrine Störungen bei Adipositas
  81. Sinnvolle Diagnostik bei Adipositas
  82. Gefäßveränderungen bei Stoffwechselerkrankungen im Kindes- und Jugendalter
  83. A Comparison of Polysomnographic Variables between Adolescents with Polycystic Ovarian Syndrome and Healthy Controls
  84. Health-related quality of life in overweight and obese youths: Results of a multicenter study
  85. Sensory preferences and discrimination ability of children before and after an obesity intervention
  86. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease
  87. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence
  88. Association between androgens, intima-media thickness and the metabolic syndrome in obese adolescent girls
  89. Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes
  90. Onset of Puberty and Cardiovascular Risk Factors in Untreated Obese Children and Adolescents
  91. A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents
  92. Two-year Follow-up in 21,784 Overweight Children and Adolescents With Lifestyle Intervention
  93. Association between leptin and transaminases: 1-year follow-up study in 180 overweight children
  94. Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups
  95. Overweight children and adolescents – is there a subjective need for treatment?
  96. Lifestyle Intervention in Obese Children With Variations in the Melanocortin 4 Receptor Gene
  97. Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention
  98. A Simple Dietary Intervention in the School Setting Decreased Incidence of Overweight in Children
  99. Prävention und Früherkennung von Krankheiten
  100. Kinder und Jugendliche mit chronischen Erkrankungen von besonderer Häufigkeit und Bedeutung
  101. Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention
  102. Sensory preferences and discrimination ability of children before and after an obesity intervention
  103. Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
  104. 'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents
  105. Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness
  106. Cardiovascular Risk in 26,008 European Overweight Children as Established by a Multicenter Database
  107. Ghrelin and Obestatin Levels in Severely Obese Women Before and After Weight Loss After Roux-en-Y Gastric Bypass Surgery
  108. Retinol-Binding Protein 4 and Its Relation to Insulin Resistance in Obese Children before and after Weight Loss
  109. The German Working Group of Obesity in Childhood and Adolescence (AGA): Improving the Quality of Care for Overweight and Obese Children in Germany
  110. Type 2 Diabetes in Children and Adolescents in a 2-Year Follow-Up: Insufficient Adherence to Diabetes Centers
  111. Adipocyte fatty acid–binding protein in obese children before and after weight loss
  112. Peptide YY and Glucagon-like Peptide-1 in Morbidly Obese Patients Before and After Surgically Induced Weight Loss
  113. Nicht länger nur eine Erkrankung des Erwachsenenalters - Epidemiologie des Diabetes mellitus Typ 2 bei Kindern
  114. Amylin and Its Relation to Insulin and Lipids in Obese Children Before and After Weight Loss*
  115. Das metabolische Syndrom im Kindes-und Jugendalter - Meist besteht bereits ein Cluster an kardiovaskulären Risikofaktoren
  116. Definable Somatic Disorders in Overweight Children and Adolescents
  117. Fasting Glucagon-like Peptide-1 and Its Relation to Insulin in Obese Children Before and After Weight Loss
  118. Reduced Sympathetic Metabolites in Urine of Obese Patients With Craniopharyngioma
  119. Epidemiologie der Adipositas im Kindes- und Jugendalter - Vor allem Umgebungsfaktoren sind schuld am Anstieg
  120. ENPP1Variants and Haplotypes Predispose to Early Onset Obesity and Impaired Glucose and Insulin Metabolism in German Obese Children
  121. Hyperthyrotropinemia in Obese Children Is Reversible after Weight Loss and Is Not Related to Lipids
  122. Positive changes of dietary habits after an outpatient training program for overweight children
  123. Intima media thickness in childhood obesity
  124. Peptide YY Is a Regulator of Energy Homeostasis in Obese Children before and after Weight Loss
  125. Longitudinal Analyses among Overweight, Insulin Resistance, and Cardiovascular Risk Factors in Children
  126. Androgens before and after Weight Loss in Obese Children
  127. High-sensitive C-reactive protein, tumor necrosis factor α, and cardiovascular risk factors before and after weight loss in obese children
  128. Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria
  129. Type 2 Diabetes Mellitus in Children and Adolescents
  130. Cardiovascular risk factors in overweight German children and adolescents: Relation to gender, age and degree of overweight
  131. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids
  132. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity
  133. Comparison of coenzyme Q10 plasma levels in obese and normal weight children
  134. Adiponectin before and after Weight Loss in Obese Children
  135. Medical care of obese children and adolescents
  136. Cortisol and Its Relation to Insulin Resistance before and after Weight Loss in Obese Children
  137. Plasma Levels of Coenzyme Q10 in Children with Hyperthyroidism
  138. Comment [from Thomas J. Scheff and Professor Emeritus]
  139. Long-Term Follow-Up of Overweight Children: After Training, After a Single Consultation Session, and Without Treatment
  140. Deletions of the Homeobox GeneSHOX(Short Stature Homeobox) Are an Important Cause of Growth Failure in Children with Short Stature
  141. Nutritional Knowledge of Obese and Nonobese Children
  142. Short stature in a mother and daughter caused by familial der(X)t(X;X)(p22.1-3;q26)
  143. Does Steroid Treatment of Abdominal Pain Prevent Renal Involvement in Henoch-Sch??nlein Purpura?
  144. Die Spondylodiszitis im Kindesalter
  145. Hyperurikämie als Leitsymptom beim Acyl-Coenzym A-Dehydrogenasedefekt mittelkettiger Fettsäuren
  146. Der Professor
  147. Professor Thomas Jonescu
  148. Introductory by Professor Huxley.
  149. Übersicht über konventionelle Therapiemöglichkeiten
  150. Adipositas
  151. Adipositas im Kindes- und Jugendalter